The effect of 6-hydroxydopamine on the antinociceptive action of morphine

European Journal of Pharmacology
P Slater, C Blundell

Abstract

The role of brain catecholamines in the antinociceptive action of morphine was investigated. Intraventricular 6-hydroxydopamine which depleted brain noradrenaline in the rat had no effect on morphine's antinociceptive action but combined treatment with pargyline and 6-hydroxydopamine to further deplete brain dopamine potentiated morphine's action. It was also shown that when dopamine receptors were blocked, the antinociceptive action of morphine was potentiated whereas alpha- and beta-adrenoceptor antagonists had no effect. 6-Hydroxydopamine had two effects in mice tested on the hot-plate. It produced a hyperalgesia and antagonized the antinociceptive action of morphine. This antagonism of morphine appeared to be the result of the depletion of noradrenaline rather than dopamine. Intraventricular injection of both catecholamines restored the antinociceptive action of morphine in 6-hydroxydopamine-treated mice but dopamine was ineffective in the presence of a dopamine beta-hydroxylase inhibitor. It is suggested that the antinociceptive action of morphine is expressed by noradrenergic neurones in the mouse and by both noradrenergic and dopaminergic neurones in the rat.

References

Aug 25, 1977·Nature·H PollardJ C Schwartz
Aug 1, 1976·European Journal of Pharmacology·E T IwamotoE L Way
Nov 28, 1975·Brain Research·M T Price, H C Fibiger
Feb 1, 1974·European Journal of Pharmacology·P Slater
Jan 1, 1972·Psychopharmacologia·I H Ayhan
Jan 1, 1970·European Journal of Pharmacology·N E AndénU Ungerstedt
Feb 1, 1970·Journal of Neurochemistry·N J Uretsky, L L Iversen
May 1, 1971·British Journal of Pharmacology·G R Breese, T D Traylor
Dec 1, 1968·European Journal of Pharmacology·U Ungerstedt
Dec 1, 1968·European Journal of Pharmacology·M W Nott
May 1, 1968·International Journal of Neuropharmacology·R A VerriA P Corrado
Dec 1, 1954·Proceedings of the Society for Experimental Biology and Medicine·J A SCHNEIDER
Mar 1, 1957·British Journal of Pharmacology and Chemotherapy·T J HALEY, W G MCCORMICK
Mar 1, 1964·The Journal of Pharmacy and Pharmacology·M MEDAKOVIC, B BANIC

❮ Previous
Next ❯

Citations

Dec 27, 1978·Naunyn-Schmiedeberg's Archives of Pharmacology·P Slater, C Blundell
Jul 1, 1980·Naunyn-Schmiedeberg's Archives of Pharmacology·P Slater, C Blundell
Oct 1, 1987·Neuropharmacology·T NabeshimaT Kameyama
Nov 1, 1990·The Journal of Pharmacy and Pharmacology·A O Oluyomi, S L Hart
May 1, 1979·Brain Research Bulletin·P A van DongenA R Cools
Jan 1, 1979·Journal of Neuroscience Research·A W Crossley, P Slater

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.